ReviewEClinicalMedicine2026

Patient-centred and fit-for-purpose clinical trials in rare cancers: lessons from sarcomas for operationalising 2024 WHO Guidance and ICH E6(R3).

Ornella Gonzato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.